Bird R E
Presbyterian Breast Center, Charlotte, NC 28204, USA.
Radiographics. 1995 Jul;15(4):928-34. doi: 10.1148/radiographics.15.4.7569137.
Screening-detected microcalcifications are responsible for more benign biopsy results than any other mammographic lesion. The management of these lesions comes at a large cost in terms of morbidity and dollars spent. Both costs and morbidity could be reduced by decreasing the number of surgical biopsies. This could be accomplished by increasing the positive biopsy rate and by substituting core needle biopsy for surgical biopsy when appropriate. To increase the positive biopsy rate, we need to improve the preoperative evaluation of microcalcifications. A scheme is presented for the mammographic evaluation of these microcalcifications and for the appropriate use of core biopsy in the management of these lesions.
与其他任何乳腺钼靶病变相比，筛查发现的微钙化灶导致的良性活检结果更多。就发病率和花费的金钱而言，这些病变的处理成本高昂。通过减少手术活检的数量，可以降低成本和发病率。这可以通过提高活检阳性率以及在适当的时候用粗针活检替代手术活检来实现。为了提高活检阳性率，我们需要改进微钙化灶的术前评估。本文提出了一种用于乳腺钼靶评估这些微钙化灶以及在这些病变管理中适当使用粗针活检的方案。
